Cardiovascular risk associated with the metabolic syndrome

被引：80
作者：
Lindsay R.S. [1 ]
Howard B.V. [1 ]
机构：
[1] MedStar Research Institute, Washington Hospital Center, Washington, DC 20010
来源：
Current Diabetes Reports | 2004年 / 4卷 / 1期
关键词：
Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; National Cholesterol Education Program; Arterioscler Thromb Vasc Biol;
D O I：
10.1007/s11892-004-0013-9
中图分类号：
学科分类号：
摘要：
The term metabolic syndrome refers to a clustering of cardiovascular risk factors, most of which also share insulin resistance as an additional feature. Scientific effort has concentrated on understanding why these diverse cardiovascular risks co-occur in individuals and in determining the presumed common environmental or genetic factors that might underpin this. Clinically important developments include publication of standard definitions of the metabolic syndrome and recommendations for the use of type 2 diabetes and the presence of the metabolic syndrome as critical "risk stratifiers" in cardiovascular disease prevention. The remarkable recent secular increases in the prevalence of type 2 diabetes and obesity in many populations mean that the importance of the metabolic syndrome as a determinant of cardiovascular disease is likely to increase until these trends can be reversed. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：63 / 68
页数：5
相关论文
共 49 条
  • [1] Liese A.D., Mayer-Davis E.J., Haffner S.M., Development of the multiple metabolic syndrome: An epidemiologic perspective, Epidemiol. Rev., 20, pp. 157-172, (1998)
  • [2] Reaven G.M., Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, pp. 1595-1607, (1988)
  • [3] Alberti K.G., Zimmet P.Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet. Med., 15, pp. 539-553, (1999)
  • [4] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, Circulation, 106, pp. 3143-3420, (2003)
  • [5] Haffner S.M., Valdez R.A., Hazuda H.P., Et al., Prospective analysis of the insulin-resistance syndrome (syndrome X), Diabetes, 41, pp. 715-722, (1992)
  • [6] Barker D.J., Fetal and infant origins of adult disease, BMJ, 301, (1990)
  • [7] Dietz W.H., Critical periods in childhood for the development of obesity, Am. J. Clin. Nutr., 59, pp. 955-959, (1994)
  • [8] Meigs J.B., Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors, Am. J. Epidemiol., 152, pp. 908-911, (2000)
  • [9] Kuusisto J., Lempiainen P., Mykkanen L., Laakso M., Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men, Diabetes Care, 24, pp. 1629-1633, (2001)
  • [10] Hanson R.L., Imperatore G., Bennett P.H., Knowler W.C., Components of the "metabolic syndrome" and incidence of type 2 diabetes, Diabetes, 51, pp. 3120-3127, (2002)
12345